These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8528964

  • 1. Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.
    Smith MR, Abubakr Y, Mohammad R, Xie T, Hamdan M, al-Katib A.
    Cancer Gene Ther; 1995 Sep; 2(3):207-12. PubMed ID: 8528964
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
    Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A.
    Clin Cancer Res; 2002 Apr; 8(4):1277-83. PubMed ID: 11948143
    [Abstract] [Full Text] [Related]

  • 3. Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.
    Morelli S, Alama A, Quattrone A, Gong L, Copreni E, Canti G, Nicolin A.
    Anticancer Drug Des; 1996 Jan; 11(1):1-14. PubMed ID: 8639245
    [Abstract] [Full Text] [Related]

  • 4. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.
    Oncogene; 1996 Jul 04; 13(1):105-15. PubMed ID: 8700536
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of treatment with antisense oligonucleotides complementary to immunoglobulin sequences of bcl-2/immunoglobulin fusion transcript in a t(14;18) human lymphoma-scid mouse model.
    Smith MR, Xie T, Zhou ZZ, Joshi I.
    Clin Cancer Res; 2001 Feb 04; 7(2):400-6. PubMed ID: 11234896
    [Abstract] [Full Text] [Related]

  • 6. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.
    Cotter FE, Johnson P, Hall P, Pocock C, al Mahdi N, Cowell JK, Morgan G.
    Oncogene; 1994 Oct 04; 9(10):3049-55. PubMed ID: 8084613
    [Abstract] [Full Text] [Related]

  • 7. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 04; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 8. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
    Gleave M, Tolcher A, Miyake H, Nelson C, Brown B, Beraldi E, Goldie J.
    Clin Cancer Res; 1999 Oct 04; 5(10):2891-8. PubMed ID: 10537358
    [Abstract] [Full Text] [Related]

  • 9. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.
    Ann Thorac Surg; 1995 Dec 04; 60(6):1583-91. PubMed ID: 8787447
    [Abstract] [Full Text] [Related]

  • 10. [The toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides incubation on cell line].
    Lin Y, Lü L, Chen Z.
    Zhonghua Yi Xue Za Zhi; 2000 Sep 04; 80(9):694-7. PubMed ID: 11798838
    [Abstract] [Full Text] [Related]

  • 11. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS, Cho-Chung YS.
    Clin Cancer Res; 2003 Mar 04; 9(3):1171-8. PubMed ID: 12631623
    [Abstract] [Full Text] [Related]

  • 12. The role of Bcl-2 protein and autocrine growth factors in a human follicular lymphoma-derived B cell line.
    Blagosklonny MV, Neckers LM.
    Eur Cytokine Netw; 1995 Mar 04; 6(1):21-7. PubMed ID: 7795171
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
    Alas S, Emmanouilides C, Bonavida B.
    Clin Cancer Res; 2001 Mar 04; 7(3):709-23. PubMed ID: 11297268
    [Abstract] [Full Text] [Related]

  • 14. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH.
    Hepatology; 1995 Sep 04; 22(3):707-17. PubMed ID: 7657273
    [Abstract] [Full Text] [Related]

  • 15. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC.
    Clin Cancer Res; 2003 Jul 04; 9(7):2826-36. PubMed ID: 12855663
    [Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases.
    Zhang H, Hoang T, Saeed B, Ng SC.
    Prostate; 1996 Aug 04; 29(2):69-76. PubMed ID: 8700802
    [Abstract] [Full Text] [Related]

  • 17. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.
    Anderegg B, Horstmann M, Kabisch H.
    Cancer Gene Ther; 1997 Aug 04; 4(2):84-90. PubMed ID: 9080116
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR, Vega MI, Chatterjee D, Goodglick L, Bonavida B.
    Cancer Res; 2004 Oct 01; 64(19):7117-26. PubMed ID: 15466208
    [Abstract] [Full Text] [Related]

  • 19. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G.
    J Leukoc Biol; 2002 Jul 01; 72(1):83-92. PubMed ID: 12101266
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.